Akinobu Hamada

5PUBLICATIONS
54CO-AUTHORS
Molecular targetsOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Preclinical Evaluation of Liposomal Eribulin (E7389-LF) in a Panel of Sarcoma Patient-Derived Xenograft Models.

|Jun 23, 2025
Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models.

Shigehiro Yagishita, Sho Sato, Daisuke Shintani

|Jul 30, 2024
Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510).

Tadaaki Nishikawa, Shigeki Kakunaga, Kenji Tamura

|Jun 18, 2024
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older.

Shigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata

|Mar 28, 2023
Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy.

Shigehiro Yagishita, Tadaaki Nishikawa, Hiroshi Yoshida

Pageof 1

Frequent Collaborators

4 joint publications

Shigehiro Yagishita

3 joint publications

Tadaaki Nishikawa

3 joint publications

Kan Yonemori

2 joint publications

Hiroshi Yoshida